摘要
急性呼吸窘迫综合征(ARDS)是常见呼吸危重症,早期诊断、早期治疗有利于改善患者预后。^(18)F-FDG PET可于分子水平对ARDS进行示踪,有助于量化肺组织炎症细胞募集及激活状态、监测肺组织区域代谢及炎症活动、揭示ARDS异质性病理改变,对ARDS早期诊断、病情监测、疗效评价等方面具有重要应用价值。本文对^(18)F-FDG PET用于ARDS的进展进行综述。
Acute respiratory distress syndrome(ARDS)is a common respiratory critical disease,and early diagnosis and treatment can improve the prognosis of ARDS patients.^(18)F-FDG PET can used to assess the ARDS on molecular level,facilitate quantifying the recruitment and activation of inflammatory cells,monitoring regional metabolism and inflammatory activity of the lung and revealing the heterogeneous pathological changes of ARDS,thus playing an important role in the early diagnosis,monitoring development and evaluating curative effect of ARDS.The application advancements of ^(18)F-FDG PET in ARDS were reviewed in this article.
作者
霍薪利
王柯
罗亮
HUO Xinli;WANG Ke;LUO Liang(School of Medicine,Nantong University,Nantong 226000,China;Jiangsu Institute of Nuclear Medicine,Wuxi 214063,China;Department of Critical Care Medicine,Wuxi No.2 People's Hospital,Affiliated Wuxi Clinical College of Nantong University,Wuxi 214000,China)
出处
《中国介入影像与治疗学》
北大核心
2021年第7期426-429,共4页
Chinese Journal of Interventional Imaging and Therapy
基金
江苏省“六大人才高峰”高层次人才项目(WSN-184)
无锡市十三五科教强卫重点医学人才项目(ZDRC007)。
